Status:
WITHDRAWN
Precision Medicine in Anesthesia
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Respiratory Depression
Eligibility:
All Genders
19-40 years
Brief Summary
This study is designed to look at how often a decrease in the rate of breathing occurs after being given a routinely used intravenous (IV) pain medication. This pain medication (Fentanyl) is given in ...
Detailed Description
Opioids are key analgesic drugs. Unfortunately, they have a high potential for abuse with potentially lethal consequences, more specifically death due to respiratory suppression. In both Canada and th...
Eligibility Criteria
Inclusion
- Healthy Subjects
- older than 19
- able to follow the study instructions
Exclusion
- Any medical condition that could affect study procedures or potentially put the subject at risk, in the opinion of the investigators
- age less than 18 or older than 40
- pregnancy
- obesity
- sleep apnea
- pulmonary problems such as moderate or severe bronchial asthma
- epilepsy
- chronic analgesic medication
- history of surgery for which details are unavailable
- allergy to fentanyl
- history of drug abuse
- positive urine test for illicit drugs
- female participants will be scheduled for a urine pregnancy test on the day of the procedure, prior to receiving study medication, only subjects with negative tests will continue
Key Trial Info
Start Date :
June 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04495452
Start Date
June 10 2024
End Date
September 1 2026
Last Update
February 5 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.